1-3 of 3
Alfred Saleh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a Phase 2 Trial Evaluating Efficacy and Safety of Entospletinib (GS-9973) in Patients with Mantle Cell Lymphoma

Jeffrey P. Sharman, Kathryn S. Kolibaba, Andrei R. Shustov, Thomas A. Giever, Leonard M. Klein, Derek Nay, Thomas A. Rado, Alfred Saleh, Danjie Zhang, Wen Shi, Andres Forero, Sarit Assouline
Journal: Blood
Blood (2016) 128 (22): 2963.
https://doi.org/10.1182/blood.V128.22.2963.2963
Published: 2016
Journal Articles

Bortezomib, Bendamustine, and Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma: Encouraging Activity in the Phase 2 VERTICAL Study.

Nathan Fowler, Brad S Kahl, Peter Rosen, Jeffrey Matous, Amanda Cashen, Samuel Jacobs, Jeffrey Letzer, Bipinkumar Amin, Michael Williams, Maureen Ross, Sonali Smith, Alfred Saleh, Hongliang Shi, Sudha Parasuraman, Bruce D. Cheson
Journal: Blood
Blood (2009) 114 (22): 933.
https://doi.org/10.1182/blood.V114.22.933.933
Published: 2009
Journal Articles

Rituximab Plus CHOP Followed by Maintenance Rituximab as Initial Therapy for Aggressive Non-Hodgkin’s Lymphoma (NHL); Initial Results of Induction Therapy, Including Rituximab Pharmacokinetics, in a Phase II Study.

Jane E. Huang, MD, Alfred Saleh, MD, J. Thomas Lee, MD, Virginia Langmuir, MD, Fan Zhang, John Hainsworth, MD
Journal: Blood
Blood (2004) 104 (11): 4616.
https://doi.org/10.1182/blood.V104.11.4616.4616
Published: 2004